Organogenesis Holdings Inc. Class A Common Stock (NASDAQ: ORGO) last traded at $1.80, down 2.17% on the session. The quote above updates while this page is open; the figures below are drawn from Organogenesis Holdings Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
Organogenesis Holdings Inc. Class A Common Stock trades on NASDAQ under the ticker ORGO. Its market capitalisation is $231.61 million.
Valuation measures for Organogenesis Holdings Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $231.61M |
|---|---|
| Enterprise value | $303.83M |
| Price / sales | 0.51 |
| Price / book | 1.56 |
| Beta | 1.23 |
Trailing-twelve-month figures tagged in Organogenesis Holdings Inc. Class A Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $457.45M |
|---|---|
| Net income (TTM) | -$84.16M |
| EPS (TTM) | -$0.790 |
| Gross margin | 76.07% |
| Operating margin | -7.84% |
| Return on equity | -56.76% |
| Cash | $46.10M |
Range and volume for ORGO over the past 52 weeks.
| 52-week high | $7.08 |
|---|---|
| 52-week low | $1.54 |
| Volume | 560.7K |
| Average volume | 852.9K |
| Previous close | $1.84 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.